Tens of thousands of children and adults living with type 1 diabetes across England are set to receive an ‘artificial pancreas’ in a world-first initiative being rolled out by the NHS.
The groundbreaking device continually monitors a person’s blood glucose, then automatically adjusts the amount of insulin given to them through a pump. Local NHS systems will start identifying eligible people living with type 1 diabetes who health chiefs believe could benefit from the Hybrid Closed Loop system- sometimes called an artificial pancreas There are currently 269,095 people living in England with type 1 diabetes.
The technology will mean some people with type 1 diabetes will no longer need to inject themselves with insulin but rely on technology to receive this life saving medication. This can also help prevent life-threatening hypoglycaemic and hyperglycaemia attacks, which can lead to seizures, coma or even death for people living with type 1 diabetes.
NHS England has provided local health systems with £2.5 million so they are ready to start identifying patients that can benefit. The mass rollout of the artificial pancreas builds on a successful pilot of the technology by NHS England, which saw 835 adults and children with type 1 diabetes given devices to improve the management of their condition. Each year, the NHS in England currently spends around £10 billion a year – around 10% of its entire budget – on identifying and treating diabetes.
Dr. Clare Hambling, National Clinical Director for diabetes said: “This is another example of the NHS leading the way in healthcare, rolling out these groundbreaking devices across England over the next 5 years.
“This transformative technology holds the power to redefine the lives of those with type 1 diabetes, promising a better quality of life as well as clinical outcomes."
